Abstract
Patients with acute leukemia who undergo hematopoietic stem cell transplantation (HSCT) are susceptible to malnutrition caused by several factors including intensive cytotoxic therapy. This paper discusses the significance of malnutrition in these patients and provides an overview of nutrition therapy by the oral, enteral, and parenteral routes. The goal is to investigate whether the use of parenteral nutrition (PN) produces improved clinical outcomes in patients with acute leukemia and to identify criteria for the selection of patients most likely to benefit from this therapy. Although PN may be appropriate for patients suffering from complications such as graft-versus-host disease (GVHD) and mucositis, the data available at this time do not support PN as first-line therapy for all recipients of HSCT.
Similar content being viewed by others
References and Recommended Reading
The Leukemia and Lymphoma Society: Leukemia Factsand Statistics. http://www.leukemia-lymphoma.org/all_page?item_id=9346. Accessed November 10, 2005.
Nitenberg G, Raynard B: Nutritional support of the cancer patient: issues and dilemmas [review]. Crit Rev Oncol Hematol 2000, 34:137–168.
Muscaritoli M, Fanfarillo F, Luzi G, et al.:Impaired nutritional status in common variable immunodeficiency patients correlates with reduced levels of serum IgA and of circulation CD4+ T lymphocytes. Eur J Clin Invest 2001, 31:544–549.
Donaldson SS, Lenon RA: Alterations in nutritional status: impact of chemotherapy and radiation therapy [review]. Cancer 1979, 43(5 Suppl):2036–2052.
Weisdorf SA, Salati LM, Longsdorf JA, et al.: Graftversus-host disease of the intestine: a protein losing enteropathy characterized by fecal alpha 1-antitrypsin. Gastroenterology 1983, 85:1076–1081.
Scrimshaw NS: Rhoades Lecture: Effect of infection on nutrient requirements. JPEN J Parenter Enteral Nutr 1991, 15:589–600.
Chang HR, Bistrian B: The role of cytokines in the catabolic consequences of infection and injury. JPEN J Parenter Enteral Nutr 1998, 22:156–166.
Bloch AS, Charuhas PM: Cancer and cancer therapy. In The Science and Practice of Nutrition Support, A Case-Based Core Curriculum. Edited by Gottschlich MM. Dubuque, Iowa: Kendall/Hunt Publishing Company 2001:643–662.
Nash RA, Pepe MS, Storb R, et al.: Acute graft versus host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood 1992, 80:1838–1845.
Lenssen P, Sherry ME, Cheney CL, et al.: Prevalence of nutrition-related problems among long-term survivors of allogeneic marrow transplantation. J Am Diet Assoc 1990, 90:835–842.
Martin PJ, McDonald GB, Sanders JE, et al.: Increasingly frequent diagnosis of acute gastrointestinal graftversus-host disease after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2004, 10:320–327.
Sonis ST, Oster G, Fuchs H, et al.: Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 2001, 19:2201–2205.
Sacks GS, Ayinala S, Donelson SS, et al.: Utilization of parenteral nutrition in patients receiving peripheral blood stem cell transplantation. J Miss State Med Assoc 2000, 41:579–584.
Lipkin AC, Lenssen P, Dickson BJ: Nutrition issues in hematopoietic stem cell transplantation: state of the art. Nutr Clin Pract 2005, 20:423–439.
Pandit MK, Burke J, Gustafson AB, et al.: Drug-induced disorder of glucose tolerance. Ann Intern Med 1993, 118:529–539.
Mattox TW: Specialized nutrition management of patients receiving hematopoietic stem cell transplantation. Nutr Clin Pract 1999, 14:5–15.
Shopbell JM, Hopkins B, Politzer Shronts E: Nutrition screening and assessment. In The Science and Practice of Nutrition Support, A Case-Based Core Curriculum. Edited by Gottschlich MM. Dubuque, Iowa: Kendall/Hunt Publishing Company; 2001:107–140.
Arfons LM, Lazarus HM: Total parenteral nutrition and hematopoietic stem cell transplantation: an expensive placebo? [review]. Bone Marrow Transplant 2005, 36:281–288.This critical review of the research available demonstrates why parenteral nutrition should not be used as first-line therapy in all HSCT patients.
Blackburn GL, Bistrian BR, Maini BS: Nutritional and metabolic assessment of the hospitalized patient. JPEN J Parenter Enteral Nutr 1977, 1:11–22.
Shils ME: Principles of nutritional therapy. Cancer 1979, 43(5 Suppl):2093–2102.
Bloch AS: Cancer. In Nutrition Support for General Systemic Disorders. Edited by Alexopoulos Y. St. Louis, MO: Saunders;2003:484–508.
Herrmann VM, Petruska PJ: Nutrition support in bone marrow transplant recipients [review]. Nutr Clin Pract 1993, 8:19–27.
Muscaritoli M, Conversano L, Cangiano C, et al.: Biochemical indices may not accurately reflect changes in nutritional status after allogeneic bone marrow transplantation. Nutrition 1995, 11:433–436.
Keller U, Kraenzlin ME, Gratwohl A, et al.: Protein metabolism assessed by 1-13C leucine infusions in patients undergoing bone marrow transplantation. JPEN J Parenter Enteral Nutr 1990, 14:480–484.
Szeluga DJ, Stuart RK, Brookmeyer R, et al.: Nutritional support of bone marrow transplant recipients: randomized clinical trial comparing total parenteral nutrition to an enteral feeding program. Cancer Res 1987, 47:3309–3316.
Lenssen P, Bruemmer BA, Bowden RA, et al.: Intravenous lipid dose and incidence of bacteremia and fungemia in patients undergoing bone marrow transplant. Am J Clin Nutr 1998, 67:927–933.
Taveroff A, McArdle AH, Rybka WB: Reducing parenteral energy and protein improves metabolic homeostasis after bone marrow transplantation. Am J Clin Nutr 1991, 54:1087–1092.
Szeluga DJ, Stuart RK, Brookmeyer R, et al.: Energy requirements of parenterally fed bone marrow transplant recipients. JPEN J Parenter Enteral Nutr 1985, 9:139–143.
Gropper SS, Smith JL, Groff JL: Advanced Nutrition and Human Metabolism, edn 4. Belmont, CA: Thomson Wadsworth; 2005.
Calle EE, Thun MJ: Obesity and cancer. Oncogene 2004, 23:6365–6378.
Chadalavada R, Parekh NR, Lopez R, et al.: Adequate home parenteral nutrition does not improve lean body mass in bone marrow transplantation patients with graft versus host disease [abstract]. Abstracts Presented at the 27th ESPEN Conference. Clin Nutr 2005, 24:680.
Roberts S: Graft-vs-host disease: nutrition therapy in a challenging condition. Nutr Clin Pract 2005, 20:440–450.
Geibig CB, Owens JP, Mirtallo JM, et al.: Parenteral nutrition for marrow transplant recipients: evaluation of an increased nitrogen dose. JPEN J Parenter Enteral Nutr 1991, 15:184–188.
Iestra JA, Fibbe WE, Zwinderman AH, et al.: Parenteral nutrition following intensive cytotoxic therapy: an exploratory study on the need for parenteral nutrition after various treatment approaches for hematological malignancies. Bone Marrow Transplant 1999, 23:933–939.
Layton PB, Galluci BB, Aker SN: Nutritional assessment of allogeneic bone marrow transplant recipients. Cancer Nurs 1981, 4:127–135.
Schmidt GM, Blume KG, Bross KJ, et al.: Parenteral nutrition in bone marrow transplant recipients. Exp Hematol 1980, 8:506–511.
Weisdorf SA, Lysne J, Wind D, et al.: Positive effect of prophylactic total parenteral nutrition on long-term outcome of bone marrow transplantation. Transplantation 1987, 43:833–838.
Wardley AM, Jayson GC, Swindell R, et al.: Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue. Br J Haematol 2000, 110:292–299.
Mattsson T, Arvidson K, Heimdahl A, et al.: Alterations in taste acuity associated with allogeneic bone marrow transplantation. J Oral Pathol Med 1992, 21:33–37.
Polisena CG: Nutrition concerns with the radiation therapy patient. In The Clinical Guide to Oncology Nutrition. Edited by McCallum PD, Polisena CG. Chicago, IL: American Dietetic Association; 2000:70–78.
Sheean PM: Nutrition support of blood or marrow dytransplant recipients: How much do we really know? Practical Gastroenterology April 2005, 84–97.
Driedger L, Burstall CD: Bone marrow transplantation. Dietitian’s experience and perspective. J Am Diet Assoc 1987, 87:1387–1388.
Weisdorf-Schindele S, Schwarzenberg SJ: Nutritional support of hematopoietic cell recipients. In Thomas’ Hematopoietic Cell Transplantation, edn 3. Edited by Blume KG, Forman SJ, Appelbaum FR. Malden, MA: Blackwell Publishing; 2004:883–893. This chapter gives a good summation of the research available on nutritional support for HSCT patients, past to present.
Hopman GD, Pena EG, Le Cessie S, et al.: Tube feeding in bone marrow transplantation. Med Pediatr Oncol 2003, 40:375–379.
Hays DM, Merritt RJ, White L, et al.: Effect of total parenteral nutrition on marrow recovery during induction from acute non-lymphocytic leukemia in childhood. Med Pediatr Oncol 1983, 11:134–140.
Hickman RO, Buckner CD, Clift RA, et al.: A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet 1979, 148:871–875.
Parker JE, Sha. T, Pagliuca A, et al.: Allogeneic stem cell transplantation in the myelodysplastic syndromes: interim results of outcome following reduced-intensity conditioning compared with standard preparative regimens. Br J Haematol 2002, 119:144–154.
Murray SM, Pindoria S: Nutrition support for bone marrow transplant patients. Cochrane Database Syst Rev 2002, 2:CD002920.
Cetin T, Arpaci F, Dere Y, et al.: Total parenteral nutrition delays platelet engraftment in patients who undergo autologous hematopoietic stem cell transplantation. Nutrition 2002, 18:599–603.
A.S.P.E.N. Board of Directors: Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr 2002, 26:82SA-85SA.These are guidelines for the use of parenteral and enteral nutrition in numerous medical conditions.
Aquino VM, Smyrl CB, Hagg R, et al.: Enteral nutritional support by gastrostomy tube in children with cancer. J Pediatr 1995, 127:58–62.
Sheean PM, Braunschweig C, Rich E: The incidence of hyperglycemia in hematopoietic stem cell transplant recipients receiving total parenteral nutrition: a pilot study. J Am Diet Assoc 2004, 104:1352–1360.
Dimick JB, Swoboda S, Talamini MA, et al.: Risk of colonization of central venous catheters: catheters for total parenteral nutrition vs. other catheters. Am J Crit Care 2003, 12:328–335.
Deshpande KS: Total parenteral nutrition and infections associated with use of central venous catheters. Am J Crit Care 2003, 12:326–327.
Van den Berghe G, Wouters P, Weekers F, et al.: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001, 345:1359–1367.
Murray MJ: Total parenteral nutrition: Can we decrease infectious complications? Crit Care Med 2000, 28:3756–3757.
Angelico M, Della Guardia P: Review article: hepatobiliary complications associated with total parenteral nutrition. Aliment Pharmacol Ther 2000, 14(Suppl 2):54–57.
Matarese LE: Metabolic complications of parenteral nutrition therapy. In The Science and Practice of Nutrition Support, A Case-Based Core Curriculum. Edited by Gottschlich MM. Dubuque, Iowa: Kendall/Hunt Publishing Company; 2001:269–286.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jacobson, N.B., Parekh, N. & Kalaycio, M. The role of parenteral nutrition. Curr Hematol Malig Rep 1, 188–194 (2006). https://doi.org/10.1007/s11899-996-0007-6
Issue Date:
DOI: https://doi.org/10.1007/s11899-996-0007-6